Insilico to contribute to Oxford CDT research and educational program in A.I
15 February 2019 - 0 comment
Thursday, February 7, 2019 – Insilico Medicine, a Rockville-based company developing the end-to-end drug discovery pipeline utilizing the next generation artificial…
Read more